Although mutations in TP53, IGF-2, and β-catenin genes have been established as drivers of sporadic ACC, the low penetrance of ACC in these genetic cancer syndromes indicates that mutations or the epigenetic regulation of the expression of nearby genes may play an important role in its etiology. Here, IGF2 is linked to adrenal cortex carcinoma.